Statistics on cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cancer Statistics: Trends and Insights
Overview of Cancer Incidence and Mortality
Cancer remains a significant public health challenge globally and in the United States. Each year, the American Cancer Society provides estimates on new cancer cases and deaths, offering a comprehensive view of cancer trends over time. In 2023, it is projected that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. This represents a slight increase from previous years, with 1,918,030 new cases and 609,360 deaths projected in 2022, and 1,898,160 new cases and 608,570 deaths in 2021.
Decline in Cancer Mortality Rates
Despite the rising number of new cases, the overall cancer death rate has been on a continuous decline since its peak in 1991. This decline is attributed to reductions in smoking, improvements in early detection, and advancements in treatment. From 1991 to 2018, the cancer death rate fell by 31%, translating to 3.2 million fewer cancer deaths than would have occurred if peak rates had persisted. By 2020, the decline had reached 29%, averting approximately 2.9 million deaths. The trend continued with a 33% reduction by 2020, resulting in an estimated 3.8 million deaths averted.
Trends in Specific Cancer Types
Lung Cancer
Lung cancer remains the leading cause of cancer death, with significant progress in reducing mortality rates. From 2014 to 2018, the annual decline in lung cancer mortality doubled, with a 5.5% decrease in men and a 4.4% decrease in women. This trend continued, with lung cancer mortality rates accelerating in decline, contributing to the largest single-year drop in overall cancer mortality of 2.2% from 2016 to 2017. In 2022, lung cancer was projected to cause approximately 350 deaths per day.
Prostate Cancer
Prostate cancer incidence has shown a mixed trend. After two decades of decline, incidence rates increased by 3% annually from 2014 through 2019, resulting in an additional 99,000 new cases. Despite this increase, mortality rates for prostate cancer have stabilized.
Breast Cancer
Breast cancer incidence has been slowly increasing, with a 0.5% annual rise from 2014 through 2018. However, the mortality rate for breast cancer has seen a slower decline compared to other cancers .
Other Cancers
Significant progress has been made in reducing mortality rates for other cancers such as melanoma, leukemia, and kidney cancer. For instance, melanoma mortality rates saw dramatic declines following the approval of new therapies, with annual declines of 7% from 2013 through 2017. Similarly, leukemia and kidney cancer mortality rates have also seen rapid declines despite stable or increasing incidence rates.
Socioeconomic and Racial Disparities
Cancer mortality rates exhibit significant disparities based on socioeconomic status and race. For example, mortality rates in the poorest counties were twice as high for cervical cancer and 40% higher for male lung and liver cancers compared to the most affluent counties. Additionally, black men have experienced the largest declines in cancer death rates across all age groups, yet disparities persist.
Conclusion
The overall decline in cancer mortality rates is a testament to the advancements in cancer prevention, early detection, and treatment. However, the rising incidence of certain cancers and persistent disparities highlight the need for targeted interventions and equitable access to cancer care. Continued investment in cancer research and the application of existing cancer control knowledge across all population segments are crucial for sustaining and accelerating progress against cancer.
Sources and full results
Most relevant research papers on this topic